You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
NORTHBROOK, Ill., Jan. 21, 2020 /PRNewswire/ -- For the sixth consecutive year, Astellas has achieved a perfect score on the Human Rights Campaign Foundation's (HRC) annual Corporate Equality...
NORTHBROOK, Ill., Jan. 8, 2020 /PRNewswire/ -- Astellas Pharma Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for...
Catherine Levitt and Charlotte Stanton named to key global and regional senior roles NORTHBROOK, Ill., Dec. 9, 2019 -- Astellas today announced the promotions of Catherine Levitt to senior vice...
Read more about Astellas Announces Key Leadership Promotions in Human Resources, Legal
Two exciting biotechs win a year of access to life-science incubator and in-house Astellas expertise to advance their early drug discovery research MENLO PARK, Calif., Dec. 5, 2019 /PRNewswire/ --...
- Four innovators awarded $200,000 in total grants and resources following live pitch event to a panel of judges that included celebrity entrepreneur Bill Rancic - NORTHBROOK, Ill., Oct. 28, 2019...
Follow U.S. news
